Aurobindo Pharma dropped 0.51% to Rs 1,305 at 11:45 IST on BSE after the stock turned ex-dividend today, 8 June 2015, for interim dividend of Rs 1 per share for the year ended 31 March 2015.
Meanwhile, the BSE Sensex was down 120.69 points, or 0.45%, to 26,647.80.
On BSE, so far 22,835 shares were traded in the counter, compared with an average volume of 1.44 lakh shares in the past one quarter.
The stock hit a high of Rs 1,327.50 and a low of Rs 1,302.85 so far during the day. The stock hit a record high of Rs 1,432.10 on 17 April 2015. The stock hit a 52-week low of Rs 627.10 on 5 June 2014.
The stock had underperformed the market over the past one month till 5 June 2015, falling 3.79% compared with 2.45% decline in the Sensex. The scrip had however outperformed the market in past one quarter, gaining 20.13% as against Sensex's 9.1% fall.
The large-cap pharma company has an equity capital of Rs 29.20 crore. Face value per share is Re 1.
Before turning ex-dividend, the stock offered a dividend yield of 0.076% based on the closing price of Rs 1,311.75 on Friday, 5 June 2015.
Aurobindo Pharma's consolidated net profit dropped 19.5% to Rs 403.80 crore on 35.5% rise in total income to Rs 3168.81 crore in Q4 March 2015 over Q4 March 2014.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
